Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
25.58
+0.58 (2.32%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Evommune Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$43.88
Upside
+71.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $48 | Buy | Reiterates | $48 | +87.65% | Apr 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $65 → $50 | Strong Buy | Maintains | $65 → $50 | +95.47% | Mar 18, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $53 | Strong Buy | Initiates | $53 | +107.19% | Mar 18, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $65 | Strong Buy | Maintains | $35 → $65 | +154.10% | Feb 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $42 | Buy | Initiates | $42 | +64.19% | Jan 22, 2026 |
| Raymond James | Raymond James | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +56.37% | Jan 8, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +36.83% | Jan 6, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 1, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $36 | Buy | Initiates | $36 | +40.73% | Dec 1, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $42 | Buy | Initiates | $42 | +64.19% | Dec 1, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +56.37% | Dec 1, 2025 |